[Federal Register: March 15, 2006 (Volume 71, Number 50)]
[Page 13410]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

Science Board to the Food and Drug Administration; Notice of 

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Science Board to the Food and Drug 
Administration Science Board (Science Board).
    General Function of the Committee: The Science Board provides 
advice primarily to the Commissioner of Food and Drugs and other 
appropriate officials on specific complex and technical issues as well 
as emerging issues within the scientific community in industry and 
academia. Additionally, the Science Board provides advice to the agency 
on keeping pace with technical and scientific evolutions in the fields 
of regulatory science, on formulating an appropriate research agenda, 
and on upgrading it's scientific and research facilities to keep pace 
with these changes. It will also provide the means for critical review 
of agency sponsored intramural and extramural scientific research 
    Date and Time: The meeting will be held on March 31, 2006, from 8 
a.m. to 4 p.m.
    Location: Food and Drug Administration, rm. 1066, 5630 Fishers 
Lane, Rockville, MD 20857.
    Contact Person: Jan Johannessen, Office of the Commissioner, Food 
and Drug Administration (HF-33), 5600 Fishers Lane, Rockville, MD 
20857, 301-827-6687, Jan.Johannessen@fda.hhs.gov, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 3014512603. Please call the Information Line 
for up-to-date information on this meeting.
    Agenda: The Science Board will conclude their discussion on drug 
safety from the meeting of November 4, 2005, and will hear about and 
discuss a request by the agency for a review of the agency's science 
programs. The Science Board will then hear about and discuss the 
agency's response to the recommendations contained in the Science 
Board's peer review of the Office of Regulatory Affairs Pesticide 
Program, plans for a Science Board peer review of the Center for 
Veterinary Medicine's intramural portion of the National Antimicrobial 
Resistance Monitoring System, and the science priorities of the 
agency's Office of Women's Health.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by March 24, 
2006. Oral presentations from the public will be scheduled between 
approximately 1 p.m. and 2 p.m. Time allotted for each presentation may 
be limited. Those desiring to make formal oral presentations should 
notify the contact person before March 24, 2006, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Jan Johannessen (see 
Contact Person) at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: March 7, 2006.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. E6-3639 Filed 3-14-06; 8:45 am]